Volume 1.18 | Sep 28

Dermal Cell News 1.18 September 28, 2015
Dermal Cell News
     In this issue: Publications | Reviews | Science News | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  DCN on Twitter
 
TOP STORY
Galectin-7 Regulates Keratinocyte Proliferation and Differentiation through JNK-miR-203-p63 Signaling
Researchers showed that galectin-7 regulates keratinocyte differentiation and proliferation through microRNA (miR)-203 but not miR-146a. A knockdown of either galectin-7 or miR-203 in keratinocytes increased expression of p63, an essential transcription factor involved in skin development. [J Invest Dermatol] Abstract
Request Sample: ReLeSR™, Easy Passaging Through Selective Detachment of hPSCs
 
PUBLICATIONS (Ranked by impact factor of the journal)
DERMAL STEM CELLS & TISSUE REGENERATION

Differential Features Between Chronic Skin Inflammatory Diseases Revealed in Skin-Humanized Psoriasis and Atopic Dermatitis Mouse Models
The authors described and characterized an animal model for atopic dermatitis using similar bioengineered-based approaches, by intradermal injection of human T helper type 2 lymphocytes in regenerated human skin after partial removal of stratum corneum. [J Invest Dermatol] Abstract

Hypermethylation of the Keap1 Gene Inactivates Its Function, Promotes Nrf2 Nuclear Accumulation, and Is Involved in Arsenite-Induced Human Keratinocyte Transformation
By establishing transformed human keratinocyte cells via chronic arsenite treatment, researchers observed a continuous reduction in reactive oxygen species levels and enhanced levels of nuclear factor E2-related factor 2 (Nrf2) and its target antioxidant enzymes in the later stage of arsenite-induced cell transformation. [Free Radic Biol Med] Abstract

Hair Follicle and Interfollicular Epidermal Stem Cells Make Varying Contributions to Wound Regeneration
By comparing the fates of several keratinocyte lineages, scientists observed an initial decrease in both hair follicle- and interfollicular epidermis-derived cells within the transient acanthotic layers of the regenerating epithelium. [Cell Cycle] Abstract

The Proteasome Immunosubunits, PA28 and ER-Aminopeptidase 1 Protect Melanoma Cells from Efficient MART-126-35 Specific T-Cell Recognition
Researchers demonstrated that the IFN-γ-inducible proteasome subunit β2i/MECL-1, proteasome activator PA28 and ER-resident aminopeptidase ERAP1 impair MART-126-35 epitope generation. [Eur J Immunol] Abstract

The Wound Healing and Antibacterial Activity of Five Ethnomedical Calophyllum inophyllum Oils: An Alternative Therapeutic Strategy to Treat Infected Wounds
Using cell and bacteria cultures, investigators confirmed the pharmacological effects of Calophyllum inophyllum oil (CIO) as wound healing and antimicrobial agent. They showed that the concentration of CIO needed to exhibit therapeutic effects are lower than concentrations exhibiting cytotoxic effects in vitro. [PLoS One] Full Article

Pharmacological Activation of Estrogen Receptors-α and -β Differentially Modulates Keratinocyte Differentiation with Functional Impact on Wound Healing
Investigators revealed that the HaCaT keratinocytes expressed both estrogen receptor (ER)-α and ‑β, and thus are well-suited for studying the effects of ER agonists on epidermal regeneration. [Int J Mol Med]
Abstract | Download Full Article

SKIN CANCERS & DISORDERS

GLUT10 Deficiency Leads to Oxidative Stress and Non-Canonical αvβ3 Integrin-Mediated TGFβ Signaling Associated with Extracellular Matrix Disarray in Arterial Tortuosity Syndrome Skin Fibroblasts
To discern the molecular mechanisms underlying the arterial tortuosity syndrome etiology, scientists performed gene expression profiling and biochemical studies on skin fibroblasts. Transcriptome analyses revealed the dysregulation of several genes involved in TGFβ signaling and extracellular matrix homeostasis as well as the perturbation of specific pathways that control both the cell energy balance and the oxidative stress response. [Hum Mol Genet] Abstract | Graphical Abstract

Lysyl Hydroxylase 3 Localizes to Epidermal Basement Membrane and Is Reduced in Patients with Recessive Dystrophic Epidermolysis Bullosa
The authors identified a significant decrease in PLOD3 expression and its encoded protein, the collagen modifying enzyme lysyl hydroxylase 3, in recessive dystrophic epidermolysis bullosa. [PLoS One] Full Article

A Novel Adamantyl Benzylbenzamide Derivative, AP736, Inhibits Melanogenesis in B16F10 Mouse Melanoma Cells via Glycogen Synthase Kinase 3β Phosphorylation
The authors investigated the novel candidate compound, AP736 (an adamantyl benzylbenzamide derivative), and its effects on melanogenesis in B16F10 melanoma cells, as well as the mechanisms involved. [Int J Mol Med] Abstract

Development of Simplified and Defined Cell Culture for hPSCs - Watch Now!
 
REVIEWS
The S100 Proteins in Epidermis: Topology and Function
Particular S100 proteins differ in their distribution in epidermal layers, skin appendages, melanocytes and Langerhans cells. Taking into account that each epidermal component consists of specialized cells with well-defined functions, such differential distribution may be indicative of the function of a given S100 protein. [Biochim Biophys Acta] Abstract

Visit our reviews page to see a complete list of reviews in the dermal cell research field.
 
SCIENCE NEWS
Combining Two Targeted Therapies Results in Melanoma Patients Living Significantly Longer
Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the combined therapy than patients treated with another drug, vemurafenib, when used alone. [Press release from the European CanCer Organisation (EurekAlert) discussing research to be presented at the 2015 European Cancer Congress (ECC), Vienna] Press Release

From our sponsor:
Learn About Groundbreaking Applications for Feeder-Free hESC & hiPSC Culture.
Watch Webinar Now
 
INDUSTRY NEWS
Syndax and Merck Announce First Patients Dosed in Phase Ib/II Clinical Trial of Entinostat And KEYTRUDA®
Syndax Pharmaceuticals, Inc. and Merck announced the dosing of the first patients in the Phase Ib/II clinical trial of Syndax’s entinostat in combination with Merck’s anti-PD-1 therapy KEYTRUDA® in patients with non-small cell lung cancer or melanoma. [Merck & Co., Inc.] Press Release

Cornell Dots Research Collaboration Leads to $10M Cancer Center
Cornell University, in partnership with Memorial Sloan Kettering Cancer Center, is opening a new $10 million Center of Cancer Nanotechnology Excellence that brings together scientists, engineers, biologists and physicians to develop and translate new cancer care applications based on nanotechnology. [Cornell University] Press Release

Caladrius Biosciences Receives Award from the National Cancer Institute
Caladrius Biosciences, Inc. announced that it has received a $300,000 contract from the National Institutes of Health’s National Cancer Institute to wholly fund the first phase of a project for process optimization of its therapeutic agent targeting tumor-initiating cells. [Caldrius Biosciences, Inc.] Press Release
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW ESMO Asia 2015 Congress
December 18-21, 2015
Singapore, Singapore

Visit our events page to see a complete list of events in the dermal cell community.
 
JOB OPPORTUNITIES
NEW Postdoctoral Position – Cancer and Developmental Biology (University of California, Irvine)

NEW Assistant Professor – Stem Cell Biology (University of South Carolina)

Senior Stem Cell Scientist (Medicines and Healthcare products Regulatory Agency)

Professor – Dermatology and Venerology (University of Munster)

Postdoctoral Fellow – Cancer Genetics (Feinberg School of Medicine)

Postdoctoral Fellow – HMGA Chromatin Remodeling Proteins in Cancer and Stem Cell Biology (Johns Hopkins University School of Medicine)

Postdoctoral Scientist – Skin Microbiome (National Human Genome Research Institute)

Assistant Professor – Cell Biology or Molecular and Cellular Mechanisms (Washington University School of Medicine)

PhD Position – Materials Engineering (IFP Energies Nouvelles)


Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Dermal Cell News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Dermal Cell News: Archives | Events | Contact Us